Antisense Therapeutics Limited
ATHJF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $11,867 | $10,967 | $19,233 | $6,020 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2,509 | $1,659 | $1,841 | $601 |
| Inventory | $0 | $0 | $613 | $0 |
| Other Curr. Assets | $38 | $66 | $533 | $77 |
| Total Curr. Assets | $14,473 | $12,692 | $22,220 | $6,699 |
| Property Plant & Equip (Net) | $57 | $151 | $217 | $302 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $57 | $151 | $217 | $302 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $14,530 | $12,843 | $22,437 | $7,001 |
| Liabilities | – | – | – | – |
| Payables | $3,729 | $1,023 | $331 | $157 |
| Short-Term Debt | $40 | $94 | $94 | $79 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,384 | $1,695 | $735 | $809 |
| Total Curr. Liab. | $5,152 | $2,812 | $1,161 | $1,046 |
| LT Debt | $0 | $48 | $133 | $227 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $15 | $7 | $1 | $0 |
| Total NC Liab. | $15 | $55 | $134 | $228 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $40 | $142 | $227 | $307 |
| Total Liabilities | $5,167 | $2,867 | $1,295 | $1,273 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $109,371 | $98,263 | $98,135 | $77,034 |
| Retained Earnings | -$101,730 | -$92,289 | -$80,909 | -$75,098 |
| AOCI | $1,722 | $4,002 | $3,916 | $3,791 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $9,363 | $9,976 | $21,141 | $5,728 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $14,530 | $12,843 | $22,437 | $7,001 |
| Net Debt | -$11,827 | -$10,825 | -$19,006 | -$5,714 |